Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

COPLEY GRAND JURY SUBPOENA RELATES TO BROMPHERIL OTC

This article was originally published in The Tan Sheet

Executive Summary

COPLEY GRAND JURY SUBPOENA RELATES TO BROMPHERIL OTC antihistamine/decongestant combination product, the company disclosed on Sept. 14. The subpoena was handed down by the U.S. Attorney's Office in Boston on Aug. 23. In a Sept. 14 press release, Copley announced a voluntary recall of the extended- release brompheniramine/pseudoephedrine product due to concerns over manufacturing procedures. The Copley brand was the first equivalent to Schering's Drixoral extended-release product to be approved by FDA in January 1987.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS083225

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel